CCM
PHVS icon

CAAS Capital Management’s Pharvaris PHVS Stock Holding History

CAAS Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,479
Closed -$251K – 1077
2021
Q2 		$251K Sell
13,479
-36,521
-73% -$829K ﹤0.01% 842
2021
Q1 		$1.4M Buy
+50,000
New +$1.57M 0.02% 700

Other funds holding PHVS

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

CAAS Capital Management's PHVS Position: Q3 2021 in Review

CAAS Capital Management sold out of Pharvaris (PHVS) in Q3 2021, closing a stake of 13,479 shares — an estimated $251K sold.

CAAS Capital Management first reported a position in PHVS in Q1 2021 and held it in 2 quarters. The position peaked at $1.4M in Q1 2021. 25 funds tracked by Wall St. Rank hold PHVS as of Q3 2021.

  • CAAS Capital Management reported no remaining Pharvaris position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 13,479 Pharvaris shares in Q3 2021, an estimated $251K.
  • CAAS Capital Management first reported a position in Pharvaris in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's Pharvaris position peaked at $1.4M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Pharvaris as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.